Session 1: Scientific updates on HIV vaccine advancements
The aim is to provide high-value scientific updates from leading researchers and organizations working at the frontier of immunogen design, bnAb discovery, and vaccine platform innovation.
Organized by the Global HIV Vaccine Enterprise and CPP Vaccine Industry Group
Audience: Open to the public, special invitation to CPP Cure and Vaccine members
